Annual report pursuant to section 13 and 15(d)

Consolidated Statements of Operations

v2.4.0.6
Consolidated Statements of Operations (USD $)
 8 Months Ended 12 Months Ended 20 Months Ended
Dec. 31, 2011
Dec. 31, 2012
Dec. 31, 2012
Income Statement [Abstract]      
Revenues         
Expenses      
Compensation and related taxes    2,676,462 2,676,462
Consulting fees    2,042,144 2,042,144
Professional fees 4,605 510,112 514,717
General and administrative 5,243 312,244 317,487
Total operating expenses 9,848 5,540,962 5,550,810
Operating loss from continuing operations (9,848) (5,540,962) (5,550,810)
Other income (expenses)      
Other income    125,000 125,000
Realized loss other than temporary decline - available for sale    (112,500) (112,500)
Interest expense    (153) (153)
Interest income    978 978
Total other income    13,325 13,325
Loss from continuing operations before provision for income taxes (9,848) (5,527,637) (5,537,485)
Provision for income taxes         
Loss from continuing operations (9,848) (5,527,637) (5,537,485)
Discontinued operations:      
Loss from discontinued operations, net of tax (99,474) (1,410,671) (1,510,145)
Net loss (109,322) (6,938,308) (7,047,630)
Less: Net loss attributable to non-controlling interest    10,496 10,496
Net loss attributable to Marathon Patent Group, Inc. $ (109,322) $ (6,927,812) $ (7,037,134)
Loss per common share, basic and diluted:      
Loss from continuing operations $ 0.00 $ (0.15) $ (0.22)
Loss from discontinued operations $ (0.01) $ (0.04) $ (0.06)
Income Loss From Operations Basic And Diluted $ (0.01) $ (0.19) $ (0.28)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING - Basic and Diluted 7,469,388 36,238,712 24,948,719